Showing 4281-4290 of 5771 results for "".
- Essilor Mourns Passing of Bernard Maitenaz, Inventor of the First Varilux Progressive Lenshttps://modernod.com/news/essilor-mourns-passing-of-bernard-maitenaz-inventor-of-the-first-varilux-progressive-lens/2478895/Essilor announced that Bernard Maitenaz, the inventor of the Varilux progressive lens that improved the lives of millions of presbyopes globally and redefined an entire industry, has passed away in his home city of Paris at the age of 94. Bernard Maitenaz’s pioneering work revolutionized
- Bausch Health To Reduce Debt By $100 Million Using Cash Generated From Operationshttps://modernod.com/news/bausch-health-to-reduce-debt-by-100-million-using-cash-generated-from-operations/2478894/Bausch Health announced it will reduce debt by $100 million through the redemption of outstanding senior secured notes, using cash generated from operations. “As Bausch Health continues its recovery from the effects of the COVID-19 pandemic, we also rema
- PYC Therapeutics Accelerates Its Pipeline of RNA Therapeutics for Ocular Diseaseshttps://modernod.com/news/pyc-therapeutics-accelerates-its-pipeline-of-rna-therapeutics-for-ocular-diseases/2478892/PYC Therapeutics announced updates to its programs and outlined its 2021-2022 corporate objectives. PYC is initially targeting inherited ocular diseases, for which it has three preclinical candidates in development. “This year we are focused on transforming PYC Therapeutics into a U.S.-bas
- AcuSurgical Raises €5.75 Million in Series A Financing to Advance its Robotic Ocular Microsurgery Platformhttps://modernod.com/news/acusurgical-raises-e5-75-million-in-series-a-financing-to-advance-its-robotic-ocular-microsurgery-platform/2478891/AcuSurgical, a French robotic microsurgery company, announced a €5.75 million Series A financing. Using advanced robotics, AcuSurgical aims to make ocular microsurgery safer and more accessible by improving the precis
- Ocuphire Initiates Enrollment in VEGA-1 Phase 2 Trial Investigating Nyxol in Presbyopiahttps://modernod.com/news/ocuphire-initiates-enrollment-in-vega-1-phase-2-trial-investigating-nyxol-in-presbyopia/2478887/Ocuphire Pharma announced that it has enrolled the first patients in a phase 2 proof of concept trial, titled VEGA-1, to evaluate a combination kit of Nyxol and low-dose pilocarpine in presbyopia. Over 12 sites representing a majority of the planned clinical sites are activated and recruiting pat
- Ophtec: Tiny ID Matrix Code Enables Fast Delivery of Premium IOLshttps://modernod.com/news/ophtec-tiny-id-matrix-code-enables-fast-delivery-of-premium-cataract-iols/2478885/Ophtec announced it has recently integrated a laser marking technology in the production process of its premium cataract IOLs. A micro ID matrix code is imprinted in the IOLs loop junctions by the laser. Using this code, special scanners can identify the IOL
- Eyevance’s Natacyn Now Available for Next-Day Deliveryhttps://modernod.com/news/eyevances-natacyn-now-available-next-day/2478883/Eyevance Pharmaceuticals announced that its anti-fungal ophthalmic medication, Natacyn (natamycin ophthalmic suspension 5%), is now available for next-day delivery. Natacyn, which Eyevance acquired from Novartis in 2019, is indicated for the treatment of fungal blepharitis, conjunctivitis,
- LumiThera Completes Patient Enrollment in LIGHTSITE III Clinical Study to Treat Dry AMDhttps://modernod.com/news/lumithera-completes-patient-enrollment-in-the-lightsite-iii-clinical-study-to-treat-dry-amd/2478882/LumiThera announced it has completed enrollment in its multicenter US clinical study in non-neovascular (dry) age-related macular degeneration (AMD) patients. The randomized, multicenter study, LIGHTSITE III, enrolled the last patient at the Byers Eye Insti
- LION Eye Group Collaborates with OCLI-Spectrum Vision Partnershttps://modernod.com/news/lion-eye-group-collaborates-with-ocli-spectrum-vision-partners/2478878/New York-based LION Eye Group announces it has entered into a collaborative agreement with OCLI-Spectrum Vision Partners (OCLI) for integrated eye care. Terms of the deal were not disclosed. “The collaboration was the result of LION’s effort to engage in high quality med
- New World Medical’s Next-Generation KDB GLIDE Now Commercially Availablehttps://modernod.com/news/new-world-medicals-next-generation-kdb-glide-now-commercially-available/2478880/New World Medical announced the launch of the KDB GLIDE device for advanced excisional goniotomy treatment of glaucoma. The KDB GLIDE, which was registered with the FDA in October 2020, is now commercially available to ophthalmic surgeons across the US looking for refined, precise performance dur